francine blumental de abreu - PHL © Elysio - FUNDAÇÃO ANTÔNIO ...

241
Solomou EE, Sfikakis PP, Kotsi P, et al. 13q deletion in chronic lymphocytic
leukemia: characterization of E4.5, a novel chromosome condensation
regulator-like guanine nucleotide exchange factor. Leuk Lymphoma 2003;
44:1579-85.
Speyer CL, Smith JS, Banda M, DeVries JA, Mekani T, Gorski DH.
Metabotropic glutamate receptor-1: a potential therapeutic target for the
treatment of breast cancer. Breast Cancer Res Treat 2012; 132:565-73.
Stankiewicz P, Lupski JR. Structural variation in the human genome and its
role in disease. Annu Rev Med 2010; 61:437-55.
Sundaresan V, Chung G, Heppell-Parton A, et al. Homozygous deletions at
3p12 in breast and lung cancer. Oncogene 1998; 17:1723-9.
Sundberg BE, Wååg E, Jacobsson JA, et al. The evolutionary history and
tissue mapping of amino acid transporters belonging to solute carrier families
SLC32, SLC36, and SLC38. J Mol Neurosci 2008; 35:179-93.
Thacker J. The RAD51 gene family, genetic instability and cancer. Cancer
Lett 2005; 219:125-35.
Thean LF, Loi C, Ho KS, Koh PK, Eu KW, Cheah PY. Genome-wide scan
identifies a copy number variable region at 3q26 that regulates PPM1L in
APC mutation-negative familial colorectal cancer patients. Genes
Chromosomes Cancer 2010; 49:99-106.
Theile M, Seitz S, Arnold W, et al. A defined chromosome 6q fragment (at
D6S310) harbors a putative tumor suppressor gene for breast cancer.
Oncogene 1996; 13:677-85.